Skip to main content
    C

    Coherus BioSciences Inc (CHRS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.51
    -0.02 (-3.73%)

    Market Cap: $81.21M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Coherus BioSciences Inc (CHRS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Coherus BioSciences are Heron Therapeuti (HRTX), TuHURA Biosciences (HURA) and Seer (SEER). By market cap, Coherus BioSciences ranks 7th of the 13 companies on this page; Codexis (CDXS) is the largest at $127.13M.

    Peer Comparison

    CHRS's ROIC of -144.8% is below the peer median of -8.4%, and its revenue growth of 23.4% is above the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Coherus BioSciences (CHRS)$81.21MN/A1.5x-253.4%-144.8%23.4%0.00%
    Heron Therapeuti (HRTX)$59.08MN/A0.4x-14.5%-8.4%-7.8%0.00%
    TuHURA Biosciences Inc (HURA)$88.58MN/AN/A0.0%-81.8%0.0%0.00%
    Seer Inc (SEER)$87.63MN/A5.8x0.0%N/A-3.4%0.00%
    Gossamer Bio Inc (GOSS)$67.10MN/A0.9x-159.5%147.4%189.1%0.00%
    Corbus Pharmaceuticals Holding (CRBP)$69.86MN/A13.9x0.0%-106.7%-100.0%0.00%
    Codexis Inc (CDXS)$127.13MN/AN/A-21.8%N/A124.0%0.00%
    Immunic Inc (IMUX)$102.61MN/AN/A0.0%N/A0.0%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Anixa Biosciences Inc (ANIX)$91.08MN/AN/A0.0%N/A0.0%0.00%
    ImmuCell Corporation (ICCC)$97.73M57.2x3.1x2.6%4.6%11.5%0.00%
    Champions Oncology Inc (CSBR)$65.49MN/A1.0x-1.9%N/A8.8%0.00%
    Coya Therapeutics, Inc. Common Stock (COYA)$73.42MN/A15.0x0.0%N/A-93.4%0.00%
    Peer median$80.53M57.2x4.5x0.0%-8.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Coherus BioSciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Heron Therapeuti (HRTX)
    Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs.
    HRTX competitors
    TuHURA Biosciences Inc (HURA)
    TuHURA Biosciences Inc is a pioneering biotechnology firm committed to advancing immunotherapy solutions for cancer and autoimmune diseases.
    HURA competitors
    Seer Inc (SEER)
    Seer, Inc., a life sciences company, is dedicated to developing and marketing products for researchers to unlock biological information.
    SEER competitors
    Gossamer Bio Inc (GOSS)
    Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing...
    GOSS competitors
    Corbus Pharmaceuticals Holding (CRBP)
    Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target...
    CRBP competitors
    Codexis Inc (CDXS)
    Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.
    CDXS competitors
    Immunic Inc (IMUX)
    Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune...
    IMUX competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    Anixa Biosciences Inc (ANIX)
    Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases.
    ANIX competitors
    ImmuCell Corporation (ICCC)
    ImmuCell Corporation, an animal health company, develops, manufactures and markets products that improve the health and productivity of dairy and beef cattle...
    ICCC competitors
    Champions Oncology Inc (CSBR)
    Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States.
    CSBR competitors
    Coya Therapeutics, Inc. Common Stock (COYA)
    Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs).
    COYA competitors

    Frequently Asked Questions About CHRS

    Who are Coherus BioSciences' main competitors?

    The companies most similar to Coherus BioSciences include Heron Therapeuti (HRTX), TuHURA Biosciences (HURA), Seer (SEER), Gossamer Bio (GOSS) and Corbus Pharmaceuticals Holding (CRBP), listed from the closest match.

    Who is Coherus BioSciences' biggest competitor?

    Codexis (CDXS) is the largest of the similar companies at $127.13M; Heron Therapeuti (HRTX) is the closest match by business profile, size, sector and industry.

    How does CHRS stock compare with its competitors?

    CHRS' P/S is 1.5x against a peer median of 4.5x; its net margin is -253.4% against a peer median of 0.0%.

    Which of Coherus BioSciences' competitors pays a higher dividend?

    Coherus BioSciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Coherus BioSciences bigger than its competitors?

    No. Coherus BioSciences is 7th by market cap among the 13 companies on this page; the largest is Codexis (CDXS) at $127.13M.